Entry and fusion inhibitors of HIV

Author： Rusconi Stefano   Bulgheroni Elisabetta   Citterio Paola  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.14, Iss.5, 2004-05, pp. : 733-748

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HIV entry and fusion inhibitors

By Chantry David  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

Fusion/entry inhibitors as therapies for HIV

By Redshaw Sally   Westby Mike  

Expert Opinion on Emerging Drugs, Vol. 6, Iss. 2, 2001-10 ,pp. : 209-224

Informa Healthcare

Access to resources Recommend Favorite

Inhibiting HIV-1 Entry with Fusion Inhibitors

By  

Current Medicinal Chemistry, Vol. 10, Iss. 17, 2003-09 ,pp. : 1633-1642

Bentham Science Publishers

Access to resources Recommend Favorite

Dissecting HIV Fusion: Identifying Novel Targets for Entry Inhibitors

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 6, Iss. 4, 2006-12 ,pp. : 355-367

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic potential of blocking HIV entry into cells: focus on membrane fusion inhibitors

By Kilby J.M.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 8, 1999-08 ,pp. : 1157-1170

Informa Healthcare

Access to resources Recommend Favorite